Latest news

Stay Updated on Our Latest Innovations

Explore the newest developments at Deciphex—from breakthroughs in AI-powered pathology to partnerships and industry insights. Stay informed on how we’re driving change in healthcare and advancing the future of diagnostics.

Featured article
March 25, 2025

Diagnexia Launches Global Education and Outreach Program to Bridge Diagnostic Gaps in Resource-Limited Regions

Diagnexia, a leader in digital pathology services, proudly announces the launch of its Global Education and Outreach Program, a transformative initiative aimed at enhancing education, diagnostic access and healthcare outcomes in regions with limited pathology resources.

Read article
Read article
Filters
Filters
Categories
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
AI
April 8, 2025

Podcast: AI's impact on Global Pathology with AI Ireland

In this episode, Deciphex CEO Donal O’Shea featured on AI Ireland's podcast to share his journey from academia to entrepreneurship, and how he’s leading the charge in transforming global pathology services with AI.
Read article
Read article
Corporate
Global
February 11, 2025

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions

Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus on advancing cutting-edge image management solutions
Read article
Read article
Diagnexia Analytix
Global
January 21, 2025

Deciphex Launches Diagnexia Analytix: AI-Driven Pathology Services for Translational Research and Development

Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.
Read article
Read article
Corporate
Global
January 7, 2025

Deciphex Secures €31M Series C to Address Global Pathology Shortage

Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising €31 million to address the acute global pathology crisis.
Read article
Read article
Diagnexia
Corporate
January 2, 2025

Diagnexia Achieves UKAS Accreditation for ISO 15189, setting a New Benchmark for Safety and Reliability in Digital Pathology

United Kingdom – Diagnexia UK Limited is delighted to announce its recent accreditation to ISO 15189:2022
Read article
Read article
Diagnexia
UK
Corporate
October 15, 2024

Diagnexia Unveils State-of-the-Art Histopathology Laboratory in Oxford

Diagnexia, the clinical digital pathology service of Deciphex, proudly announces the opening of a new, cutting-edge histopathology laboratory in Oxford.
Read article
Read article
Global
Patholytix
Corporate
September 16, 2024

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation
Read article
Read article
Diagnexia
Global
September 16, 2024

Diagnexia Receives Accreditation from the College of American Pathologists

Diagnexia has successfully met the rigorous standards set by the College of American Pathologists (CAP).
Read article
Read article
Patholytix
Corporate
Ireland
May 30, 2024

Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies

Deciphex announces that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies.
Read article
Read article
Diagnexia
UK
April 30, 2024

Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park

Diagnexia, the digital pathology diagnostics leader and a division of Deciphex, today unveiled its strategic relocation to a larger facility within Exeter Science Park.
Read article
Read article
AI
Global
Patholytix
April 23, 2024

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development
Read article
Read article
Patholytix
Corporate
April 11, 2024

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices
Read article
Read article
Diagnexia
Global
February 21, 2024

Diagnexia Partners with Aga Khan University Hospital to Enhance Pathology Services and Foster AI Diagnostic Innovations

Diagnexia, a leader in pathology expertise, is thrilled to announce a significant collaborative agreement with Aga Khan University Hospital (AKUH), Nairobi.
Read article
Read article
Patholytix
Corporate
February 20, 2024

Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider

In 2023, a Toxicological Pathologist at Integrated Biologix GmbH, Sarah Taplin, became the first consultant pathologist to perform a regulated digital peer review for a study conducted at a drug development research provider.
Read article
Read article
Corporate
January 4, 2024

Deciphex Welcomes Dr. Pierre Moulin as Chief Scientific Officer to Help Shape the Future of Pathology AI

Deciphex, an innovator in Pathology AI, announces the strategic appointment of Dr. Pierre Moulin as Chief Scientific Officer.
Read article
Read article
December 14, 2023

Deciphex Celebrates Double Triumph: Medtech Company of the Year and Digital Health Innovation of the Year 2023

Deciphex is delighted to announce its recognition at the Irish Medtech Awards 2023.
Read article
Read article
Corporate
October 16, 2023

Deciphex Secures €10m Venture Debt Financing to Accelerate Digital Pathology and AI Services Expansion

Deciphex, a trailblazer in digital pathology solutions, is delighted to announce a successful €10m venture debt financing round.
Read article
Read article
Patholytix
UK
August 24, 2023

Deciphex Accepted into MHRA GLP Monitoring Programme and Imminent Attainment of GLP Certification at Exeter Site

Deciphex, a pioneering leader in digital pathology solutions, is pleased to announce the acceptance of, Diagnexia UK Limited, into the Medicines and Healthcare products Regulatory Agency (MHRA) GLP Monitoring Programme as a prospective member, and the expected achievement of Good Laboratory Practice (GLP) compliance statement for its cutting-edge facility located in Exeter.
Read article
Read article
Diagnexia
Global
June 22, 2023

Diagnexia Expands Pathology Services with State-of-the-Art Accessioning Facility in Toronto, Revolutionizing Digital Pathology and Enhancing Patient Care

The Toronto Diagnexia Accessioning Office is Now Open
Read article
Read article
Diagnexia
UK
April 19, 2023

Diagnexia Announces Exeter Accession Facility Expansion with 30 New Jobs

The company has seen a 450% increase in demand for services since December. The expansion is expected to create numerous employment opportunities in the Exeter region, further stimulating the local economy.
Read article
Read article
Corporate
Global
January 25, 2023

Deciphex Secures €3.9m Funding to Boost Digital Pathology and AI Services

The company is seeing a ten fold increase in demand quarterly and this strategic investment will allow them to grow their capacity, increase headcount, further improve services and expand to new markets.
Read article
Read article
Patholytix
Global
September 13, 2022

Patholytix Validated for GLP Primary and Peer Review

Reduces Time and Cost of Safety Assessment Studies
Read article
Read article
Global
Diagnexia
September 7, 2022

Digital pathology leader, Deciphex, launches its Diagnostics as a service (DxaaS) in the United States

Diagnexia is the first fully digital, subspecialty led, remote diagnostic & consult service.
Read article
Read article
Patholytix
Global
June 7, 2022

Deciphex Enables Digital Pathology Primary Review for GLP Studies

Deciphex have announced today that they are first in industry to offer clients Good Laboratory Practice (GLP) compliant digital primary review.
Read article
Read article
Corporate
Global
May 19, 2022

Irish Digital Pathology and AI Company, Deciphex, Raises $11.5M in Series B Funding Led by ACT Venture Capital

Investment will fuel Deciphex’s role in using AI to accelerate pathology diagnostics, improving productivity and patient outcomes.
Read article
Read article
Patholytix
Corporate
March 16, 2022

Deciphex Announce the Release of New Service Which Enables Veterinary Consultant Pathologists to Easily Onboard Digital Studies From Their Partners via Patholytix Preclinical

Deciphex have introduced a new service to facilitate on-demand sharing of studies with any veterinary consultant pathologist on a pay-per-use basis with zero cost to the consultant.
Read article
Read article
Diagnexia
UK
December 1, 2021

Diagnexia Launch the UK’s First, Fully Digital, Subspeciality Led, Backlog Management and Consult Service

Diagnexia, a new generation of technology-enabled care provider, powered by Deciphex’s core technologies, announces that they have secured CQC (Care Quality Commission) certification.
Read article
Read article
No results found.
There are no results with this criteria. Try changing your search.